Chemoinformaics analysis of 4,4-DIMETHYLOXOLANE-2,3-DIONE
| Molecular Weight | 128.127 | nRot | 0 |
| Heavy Atom Molecular Weight | 120.063 | nRig | 6 |
| Exact Molecular Weight | 128.047 | nRing | 1 |
| Solubility: LogS | -3.007 | nHRing | 1 |
| Solubility: LogP | 2.143 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 17.7603 |
| nHD | 0 | BPOL | 11.4977 |
| QED | 0.554 |
| Synth | 3.171 |
| Natural Product Likeliness | 0.934 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.027 |
| Pgp-sub | 0.001 |
| HIA | 0.017 |
| CACO-2 | -5.11 |
| MDCK | 0.00000945 |
| BBB | 0.892 |
| PPB | 0.664729 |
| VDSS | 0.315 |
| FU | 0.235011 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.613 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.178 |
| CYP2c9-inh | 0.038 |
| CYP2c9-sub | 0.939 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.57 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.048 |
| CL | 12.918 |
| T12 | 0.883 |
| hERG | 0.007 |
| Ames | 0.023 |
| ROA | 0.033 |
| SkinSen | 0.882 |
| Carcinogencity | 0.82 |
| EI | 0.972 |
| Respiratory | 0.254 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.940761 |